Infosys has filed a counterclaim against Cognizant in a Texas federal court, accusing the U.S.-based firm and its CEO, Ravi Kumar, of engaging in anti-competitive practices and misusing sensitive information. The lawsuit, filed on January 9, 2025, highlights a contentious rivalry between the two IT giants, particularly as the industry navigates challenges posed by an uncertain U.S. economy and the rise of artificial intelligence. Infosys alleges that Cognizant employed monopolistic tactics to undermine competition, particularly targeting its healthcare insurance offering, Helix, which Infosys began developing in 2019. This legal action follows a prior lawsuit initiated by a Cognizant subsidiary against Infosys approximately five months earlier, further escalating the conflict over alleged poaching of key executives and the misuse of trade secrets.